GLP-1 Market Update: Size, Share, Competitive Landscape, and Future Trends to 2035

The global GLP-1 market size is likely to grow from USD 49.3 billion in 2024 to USD 157.5 billion by 2035, growing at a CAGR of 11.1% during the forecast period, till 2035.
GLP-1 drugs market has garnered significant traction within the medical science domain. Concurrently, the rising demand and escalating prevalence of metabolic disorder including type 2 diabetes and obesity are fueling the need for treatments capable of effectively managing these conditions.
GLP-1drugs: market landscape. The current market landscape features the presence of more than 150 GLP-1 drug candidates, intended for the treatment of multiple indications, are currently either approved or being investigated by pharmaceutical companies, that are currently available in the market or under different stages of development. Majority (close to 60%) of the GLP-1 drug candidates are currently being evaluated in clinical stages of development; of these, most of the candidates target metabolic disorders, such as Type 2 diabetes and obesity.

Read More - https://www.rootsanalysis.com/....reports/glp-1-market